- Syneron Medical (NASDAQ:ELOS) Q3 results: Revenues: $62.1M (+3.0%); Operating Expenses: $41.4M (+24.0%); Operating Loss: ($7.1M) (-545.5%); Net Loss: ($6.5M) (-182.6%); Loss Per Share: ($0.18) (-200.0%); Non-GAAP EPS: $0.03 (unch); Quick Assets: $71.1M (-24.1%).
- No guidance given.